These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1002997)

  • 41. Acidic "peptidophospholipids", a new class of hapten-bearing cell surface modifying reagents.
    Weltzien HU; Matthiessen HP; Meyer-Delius M; Zimmermann F; Rüde E
    Mol Immunol; 1984 Sep; 21(9):801-10. PubMed ID: 6207427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3-phenylazo-4-hydroxyphenylisothiocyanates: reagents for efficient haptenation of immunoglobulin and other carrier molecules.
    Simmonds RG; Smith W; Marsden H
    J Immunol Methods; 1982 Oct; 54(1):23-30. PubMed ID: 7142717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hapten-Anti-Hapten Technique for Two-Color IHC Detection of Phosphorylated EGFR and H2AX Using Primary Antibodies Raised in the Same Host Species.
    Hagen J; Schwartz D; Kalyuzhny AE
    Methods Mol Biol; 2017; 1554():155-160. PubMed ID: 28185188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. UltraPlex Hapten-Based Multiplexed Fluorescent Immunohistochemistry.
    Levin M; Flor AC; Snyder H; Kron SJ; Schwartz D
    Methods Mol Biol; 2021; 2350():267-287. PubMed ID: 34331291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction of purified antibody with homologous hapten; antibody valence and binding constant.
    EISEN HN; KARUSH F
    J Am Chem Soc; 1949 Jan; 71(1):363. PubMed ID: 18108974
    [No Abstract]   [Full Text] [Related]  

  • 46. Quantitation of antibody binding to cell surface antigens by x-ray fluorescence spectrometry.
    Goldin EM; Corry PM; Granatek CH
    Biochim Biophys Acta; 1979 Mar; 552(1):120-8. PubMed ID: 435491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome.
    Han X; Lin H; Chen X; Wang L; Zhang Z; Wei X; Sun X; Xie H; Pavase TR; Cao L; Sui J
    Front Immunol; 2023; 14():1144020. PubMed ID: 37342337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased antigenicity of coupled hapten-protein antigen resulting from treatment with too much hapten.
    BOYD WC; WARSHAVER ER
    J Immunol; 1946 Jan; 52():97-9. PubMed ID: 21012789
    [No Abstract]   [Full Text] [Related]  

  • 49. Theory of equilibrium binding of a bivalent ligand to cell surface antibody: the effect of antibody heterogeneity on cross-linking.
    Goldstein B; Wofsy C
    J Math Biol; 1980 Dec; 10(4):347-66. PubMed ID: 7276759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-surface modification with an iodinatible imidoester to enhance radiolabeling.
    Wall KA; Fitch FW
    J Immunol Methods; 1985 Feb; 77(1):1-8. PubMed ID: 3871820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The isolation and some properties of the Forssman hapten from sheep erythrocytes.
    PAPIRMESITER B; MALLETTE MF
    Arch Biochem Biophys; 1955 Jul; 57(1):94-105. PubMed ID: 13239189
    [No Abstract]   [Full Text] [Related]  

  • 52. Affinity labeling of rabbit antisaccharide antibodies.
    Wofsy L; Kimura J; Bing DH; Parker DC
    Biochemistry; 1967 Jul; 6(7):1981-8. PubMed ID: 6049440
    [No Abstract]   [Full Text] [Related]  

  • 53. Recovering antibody secretion using a hapten ligand as a chemical chaperone.
    Wiens GD; O'Hare T; Rittenberg MB
    J Biol Chem; 2001 Nov; 276(44):40933-9. PubMed ID: 11533029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The nature of the combining sites of antibodies; the specific protection of the combining site by hapten during iodination.
    PRESSMAN D; STERNBERGER LA
    J Immunol; 1951 May; 66(5):609-20. PubMed ID: 14832480
    [No Abstract]   [Full Text] [Related]  

  • 55. Rh antigen and hapten; nature of antigen and its isolation from erythrocyte stroma.
    CALVIN M; EVANS RS
    Proc Soc Exp Biol Med; 1946 Apr; 61():416-9. PubMed ID: 20982515
    [No Abstract]   [Full Text] [Related]  

  • 56. Experiences with Rh hapten.
    GOLDSMITH JW
    Wis Med J; 1950 May; 49(5):381-4. PubMed ID: 15418841
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rh-hapten prophylaxis].
    HOLLANDER R
    Med Klin; 1951 Apr; 46(14):441-3. PubMed ID: 14842557
    [No Abstract]   [Full Text] [Related]  

  • 58. Activation of the Forssman hapten in the inhibition assay.
    PAPIRMEISTER B; MALLETTE MF
    Arch Biochem Biophys; 1955 Jul; 57(1):106-14. PubMed ID: 13239190
    [No Abstract]   [Full Text] [Related]  

  • 59. [Synthesis of 6-mercaptopurine-protein conjugates with imido-acid ester coupling. 19. Immunosuppressive antigen conjugates].
    Wagner G; Hanfeld V; Pischel H
    Pharmazie; 1977 Dec; 32(12):748-50. PubMed ID: 613312
    [No Abstract]   [Full Text] [Related]  

  • 60. A critical appraisal of the present status of "Rh hapten".
    GREENWALT TJ
    Wis Med J; 1950 Aug; 49(8):711-2. PubMed ID: 15431674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.